Non Hormonal Advantage Madorra offers a non-hormonal, at-home medical device to treat vaginal atrophy, appealing to postmenopausal women and breast cancer survivors seeking non-pharmacological options. This creates a compelling value proposition for clinics, hospitals, and direct-to-consumer channels targeting women’s health.

Home-Use Accessibility The device is designed for easy at-home use, enabling direct-to-consumer sales, telehealth partnerships, and subscription models. Consider upsell opportunities with accessories, consumables, and extended warranty services to drive recurring revenue.

Clinical Validation Madorra has secured NIH Fast-track SBIR support and is pursuing formal clinical validation for a hormone-free device, which can be leveraged in partnerships with medical practitioners, fertility and menopause clinics, and payer discussions to support reimbursement.

Targeted Demographics Primary markets include postmenopausal women and breast cancer survivors, a segment with unmet needs and potential high lifetime value. Tailor outreach to gynecology practices, oncologist networks, and survivor support groups to generate B2B and B2C opportunities.

Growth Potential With revenue in the low-to-mid millions and a focused product line, opportunities exist to expand into adjacent women’s health devices, raise strategic partnerships, and pursue co-marketing with established players in medical devices and women’s health tech to accelerate adoption.